Skip to main content
SpringerPlus
Fig. 1 | SpringerPlus

Fig. 1

From: Risk factors and influence of carbapenem exposure on the development of carbapenem resistant Pseudomonas aeruginosa bloodstream infections and infections at sterile sites

Fig. 1

a Antibiogram for P. aeruginosa isolates at UCH from 2002 to 2011. Arrow denotes implementation of house-wide restriction of fluoroquinolones. P/T piperacillin/tazobactam, GNT gentamicin, IMI imipenem, MER meropenem, DORI doripenem, CTX ceftazidime, CIP ciprofloxacin. b Antibiotic usage at UCH from 2004 to 2011. There was a significant decrease of fluoroquinolones after restriction in 2004

Back to article page